메뉴 건너뛰기




Volumn 6, Issue 6, 2011, Pages 1067-1073

Diverse clinical compounds alter the quaternary structure and inhibit the activity of an essential enzyme

Author keywords

Allosterism; Inhibitors; Lyases; Morpheeins; Proteins

Indexed keywords

2,4 DINITROANISOLE; ARTHROTEC; BENDROFLUMETHIAZIDE; COPPER SULFATE; DIBROMOSALICYLALDEHYDE; DICLOFENAC; DICLOFENAC POTASSIUM; ENZYME INHIBITOR; ENZYME VARIANT; FLUFENAMIC ACID; MECLOFENAMIC ACID; NIFLUGEL; NIFLUMIC ACID; NITROFURAL; OXANTEL; PENNSAID; PORPHOBILINOGEN SYNTHASE; PORPHOBILINOGEN SYNTHASE INHIBITOR; PV 10; ROSE BENGAL; SOLARAZ; TOLFENAMIC ACID; UNCLASSIFIED DRUG; ZIPSOR;

EID: 79957607075     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100009     Document Type: Article
Times cited : (14)

References (38)
  • 22
    • 79957601581 scopus 로고    scopus 로고
    • American Porphyria Foundation, Houston, TX (USA), 2010: (accessed March 11, 2011).
    • American Porphyria Foundation, Houston, TX (USA), 2010: (accessed March 11, 2011).
  • 37
    • 79957617828 scopus 로고    scopus 로고
    • W.S. Rasband, US National Institutes of Health, Bethesda, MD (USA), 1997-2009.
    • W.S. Rasband, US National Institutes of Health, Bethesda, MD (USA), 1997-2009.
  • 38
    • 79957594631 scopus 로고    scopus 로고
    • SigmaPlot, 10th ed., Systat Software Inc., Port Richmond, CA (USA), 2006.
    • SigmaPlot, 10th ed., Systat Software Inc., Port Richmond, CA (USA), 2006.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.